Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 17, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Upcoming Healthcare Conferences

REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
May 16, 2022 08:00 ET | Source: Codexis, Inc.

Codexis Presents Pre-Clinical Data Highlighting Gene Therapy Programs at the ASGCT 25th Annual Meeting

REDWOOD CITY, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that three of its...
May 05, 2022 16:05 ET | Source: Codexis, Inc.

Codexis Reports First Quarter 2022 Financial Results

Total Revenue up 96% and Product Revenue up 200% YOY; Product Gross Margin Expands to 72% Reiterating Guidance for 2022, Including Total Revenue of $152 - $158M REDWOOD CITY Calif., May 05, 2022 ...
May 02, 2022 16:35 ET | Source: Codexis, Inc.

Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual Meeting

REDWOOD CITY, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced two poster...
April 21, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Report First Quarter 2022 Financial Results on May 5

REDWOOD CITY, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that it will...
April 21, 2022 08:00 ET | Source: Codexis, Inc.

Codexis and seqWell Announce Strategic Investment and Partnership Initiation

seqWell raises $7M Series C funding, led by CodexisCurrent investors Research Corporation Technologies and BroadOak Capital Partners also participated in the roundNew funding will be used to...
April 12, 2022 08:00 ET | Source: Codexis, Inc.

Codexis and Molecular Assemblies Announce Results of First Collaboration on a Proprietary High Performing DNA Polymerase to Supercharge Fully Enzymatic DNA Synthesis

Molecular Assemblies has pioneered Fully Enzymatic Synthesis™ (or FES™) technology with an in-process purification step to overcome the length, purity, and accuracy limitations of the current chemical...
March 01, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in the Cowen 42nd Annual Health Care Conference

REDWOOD CITY, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
February 24, 2022 16:05 ET | Source: Codexis, Inc.

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Record Annual Total Revenue of $104.8M, Representing Eighth Consecutive Year of Revenue Growth Company Guides to 2022 Total Revenues of $152-$158M; Product Revenues of $112-$118M REDWOOD CITY,...
February 10, 2022 16:05 ET | Source: Codexis, Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that it will...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right